Skip to main content

4 Result(s)

within Thomas Heinicke Remove this filter

and
Your search also matched 8 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters

Include preview-only content

  1. Article

    Open Access

    Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia

    Thomas Burmeister, Aeint-Steffen Ströh, Britta Kehden, Heiko Trautmann… in Leukemia (2024)

    Download PDF (1088 KB) View Article

  2. Article

    Open Access

    Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study

    A randomized inter-group trial comparing more intensive treatment strategies to a common standard arm 3 + 7 (CSA) was conducted in patients with non-M3 AML. Untreated patients ≥ 60 years were allocated to the ...

    Dietger Niederwieser, Thomas Lang, Rainer Krahl, Thomas Heinicke… in Annals of Hematology (2023)

    Download PDF (3229 KB) View Article

  3. Article

    Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials

    Thomas Heinicke, Rainer Krahl, Christoph Kahl, Michael Cross… in Annals of Hematology (2021)

    Download PDF (1176 KB) View Article

  4. Article

    Open Access

    Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials

    Relapse of acute leukemia is a frequent complication with uncertain outcome and poorly defined risk factors. From 1621 patients entered into two prospective clinical trials (AML02; n = 740 and AML04; n = 881),...

    Thomas Heinicke, Rainer Krahl, Christoph Kahl, Michael Cross… in Annals of Hematology (2021)

    Download PDF (2787 KB) View Article